Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia Pacific Digital Genome Market Forecast 2021-2028

Published by Inkwood Research Product code 991378
Published Content info 142 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Digital Genome Market Forecast 2021-2028
Published: March 1, 2021 Content info: 142 Pages
Description

KEY FINDINGS

The Asia Pacific digital genome market is registered to grow with a CAGR of 10.37%, across the forecast years of 2021 to 2028. The rising research and development, the increasing genomics programs, the growing funding for genomics, and the surging prevalence of chronic diseases are expected to supplement the region's market growth.

MARKET INSIGHTS

The Asia Pacific digital genome market growth is analyzed through the evaluation of China, South Korea, Vietnam, Australia & New Zealand, India, Indonesia, Japan, Thailand, and the rest of the Asia Pacific. India has undertaken the project for human genome diversity, under the Department of Biotechnology's human genetics program. The project was launched at the Indian Statistical Institute (ISI), the Indian Institute of Chemical Biology (IICB), and the Saha Institute of Nuclear Physics (SINP), in 1999, in Kolkata. Thereafter, India's biotechnology division bolstered and witnessed tremendous developments and changes. In 2020, the Department of Biotechnology (DBT) sanctioned the Genome India Project (GIP), entailing a collaboration of 20 institutes, including the Indian Institute of Science. The GIP will encourage new efficiencies in life sciences, medicine, and agriculture.

On the other hand, the government of Thailand launched the Genomics Thailand Initiative in 2019, in order to sequence the genomes of 50,000 Thais, and build the infrastructure to harness genetic data. The project aims to better understand Southeast Asia's unique genome complexities and advances in terms of drug selection and personalized diagnostics. Moreover, it also includes treatments in the avenues of cancer, non-communicable diseases, rare diseases, and infectious conditions. Thus, these factors are anticipated to propel the market growth, over the forecast period.

COMPETITIVE INSIGHTS

Leading companies operating in the region's market are, Qiagen, F. Hoffman-La Roche Ltd, Illumina Inc, Thermo Fisher Scientific Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36134

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
    • 3.1.2. ADVANCEMENTS IN TECHNOLOGY
    • 3.1.3. SURGING PREVALENCE OF CHRONIC DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
    • 3.2.2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SEQUENCING AND ANALYZER INSTRUMENTS
  • 5.2. DNA/RNA ANALYSIS
  • 5.3. SEQUENCING AND ANALYSIS SOFTWARE
  • 5.4. SEQUENCING CHIPS
  • 5.5. SAMPLE PREP INSTRUMENTS

6. MARKET BY APPLICATION

  • 6.1. DIAGNOSTICS
  • 6.2. DRUG DISCOVERY
  • 6.3. ACADEMIC RESEARCH
  • 6.4. PERSONALIZED MEDICINE
  • 6.5. AGRICULTURAL
  • 6.6. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. DIAGNOSTICS AND FORENSIC LABS
  • 7.2. ACADEMIC RESEARCH INSTITUTES
  • 7.3. HOSPITALS
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. ASIA PACIFIC
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. CHINA
      • 8.1.5.2. JAPAN
      • 8.1.5.3. AUSTRALIA & NEW ZEALAND
      • 8.1.5.4. INDIA
      • 8.1.5.5. SOUTH KOREA
      • 8.1.5.6. THAILAND
      • 8.1.5.7. INDONESIA
      • 8.1.5.8. VIETNAM
      • 8.1.5.9. REST OF ASIA PACIFIC

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILE
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. AGILENT TECHNOLOGIES INC
    • 9.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 9.2.4. BIOMERIEUX SA
    • 9.2.5. BIO-RAD LABORATORIES INC
    • 9.2.6. F. HOFFMANN-LA ROCHE
    • 9.2.7. ILLUMINA INC
    • 9.2.8. INSCRIPTA
    • 9.2.9. OXFORD NANOPORE TECHNOLOGIES LTD
    • 9.2.10. PACIFIC BIOSCIENCE
    • 9.2.11. PERKINELMER INC
    • 9.2.12. QIAGEN NV
    • 9.2.13. REGENERON PHARMACEUTICALS
    • 9.2.14. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME
  • TABLE 2: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN ASIA PACIFIC DIGITAL GENOME MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: ASIA PACIFIC DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, IN 2020
  • FIGURE 12: ASIA PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, IN 2020
  • FIGURE 19: ASIA PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: ASIA PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: ASIA PACIFIC DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: ASIA PACIFIC DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: CHINA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: JAPAN DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: INDIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: SOUTH KOREA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: THAILAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: INDONESIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: VIETNAM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: REST OF ASIA PACIFIC DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
Back to Top